European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Almirall SA, Barcelona, Spain

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Almirall SA
Laboratorios Almirall SA

Register

Regmer
Registro Mercantil A58869389
Sirul
Siren 493879316
Stockp
ALM.MC
Stockp
LBTSF
Sirul
Siret 49387931600013
Lei
95980020140005007996

Address

Ronda Del General Miter, 151, 08022 Barcelona, Spain

Corporate purpose

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Additional info

21.20
Manufacture of pharmaceutical preparations

Financials

History

Legal Representatives

Marketing & Tech

Network

Loading network
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Publications

18 Jun 2024
No longer Officer (2)
18 Jun 2024
Capital: €25.6M
10 Jun 2024
Chair: Iglesias Eva Abans · Vice Chair: E. de Leyva Perez · Board: Iglesias Eva Abans, Ugo di Francesco, Dobber Ruud · No longer Chair: E. de Leyva Perez · No longer Vice Chair (1) …
10 Jun 2024
Other items: Capital Increase Agreement dated May 10, 2024
10 Jun 2024
Company statute
17 Apr 2024
Officer: Alba F. X. Llaurado, M. Soriano Campuzano
1 Apr 2024
Officer: M. Soriano Campuzano
Year 2024 in Euipotm
4 trademark filings (1 wordmark, 3 word figurative marks): SIMPLE OUTSIDE CLEVER INSIDE …
22 Feb 2024
No longer Officer (2)
2 Feb 2024
Agencia Estatal Boletín Oficial del Estado (anuncios únicos)
31 Jan 2024
Officer: Maria Avila Ramirez
31 Jan 2024
Officer: A. Lugo Rodriguez
18 Jan 2024
Officer: Marie J. Nathalie
18 Jan 2024
Officer: Marta Guirado Viedma, E. Urgelles Camprubi
31 Dec 2023
Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
Year 2023 in Euipotm
7 trademark filings (5 wordmarks, 1 figurative mark, 1 word figurative mark): Almirall FOTOfarma, Almirall PHOTOpharma, ETULIRZ, ETUZRA, VOVELDI …
22 Nov 2023
No longer Officer (1)
22 Nov 2023
Officer: Maria Calvo Romero
16 Nov 2023
Chair of the board: E. de Leyva Perez · Member of the board (3)
3 Nov 2023
Other concepts: Amendment of Article 15 of the Regulations of the Board of Directors and Introduction to the same ...
18 Jul 2023
No longer Officer (1)
18 Jul 2023
Officer (1)
22 Jun 2023
Capital: €25.1M
7 Jun 2023
Capital: €22.2M
1 Jun 2023
CEO: C. Gallardo Pique · Chair of the board: E. de Leyva Perez, C. Gallardo Pique, J. Orlow Seth · Member of the board (8) · Secretary (3) · No longer Secretary (4) · Vice chair of the board (1)
1 Jun 2023
Company statute
1 Jun 2023
Other concepts: Capital Increase Agreement dated May 5, 2023
1 Jun 2023 in France
Segment clas­si­fi­ca­tion
24 May 2023
Secretary: C. Gallardo Pique
30 Mar 2023
Officer (2)
10 Feb 2023
No longer Officer (1)
8 Feb 2023
Agencia Estatal Boletín Oficial del Estado (anuncios únicos)
31 Dec 2022
Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
29 Dec 2022
No longer Member of the board (1) · No longer Secretary (1)
Year 2022 in Euipotm
6 trademark filings (5 wordmarks, 1 word figurative mark): ACLIFORM-COPD, BREANTIS, DUVEKLIR, OMEGA, SKYLIRANCE …
14 Dec 2022
CEO: C. Gallardo Pique · Member of the board: E. de Leyva Perez · No longer CEO (1)
11 Oct 2022
Secretary (1) · No longer Secretary (1)
1 Sept 2022
Officer (1)
1 Sept 2022
No longer Officer (1)
2 Aug 2022
Other items: Admission to trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges of 1,738,566 ...
20 Jul 2022
Officer (1)
1 Jul 2022
Officer (1)
1 Jul 2022
No longer Officer (2)
9 Jun 2022
Chair of the board (1)
9 Jun 2022
Officer: C. Gallardo Pique · No longer Officer (1)
9 Jun 2022
No longer Vice chair of the board: C. Gallardo Pique · No longer Member of the board (2)
9 Jun 2022
Capital: €21.8M
Year 2022 in Epobase
4 European patent filings: Aclidinium for USE in Increasing Physical Activity in Daily Life in a Patient Suffering From Chronic Obstructive Pulmonary Disease …
31 May 2022
Chair of the board: C. Gallardo Pique · No longer Chair of the board (1) · No longer Member of the board (1)
9 May 2022
Officer (1)
3 Mar 2022
No longer Officer (4)
3 Mar 2022
Officer (1)
21 Jan 2022
Other items: Total Cancellation of INS.265 and 276 of Issuance of Convertible Debentures dated 14 ...
31 Dec 2021
Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
Year 2021 in Epobase
5 European patent filings: Pyrimidine Substituted Derivatives AS TYK2 Inhibitors …
Year 2021 in Euipotm
4 trademark filings (2 wordmarks, 2 word figurative marks): BERENGUER-INFALE, PANTOFARMA …
3 Nov 2021
Officer (1)
3 Nov 2021
No longer Officer (2)
21 Oct 2021
Amount of the issue: 300,000,000.00 Euros. 20.09.21
21 Oct 2021
Other items: Proof of Subscription and Disbursement of the Issued Debentures, for ONE Total Nominal Value of ...
14 Oct 2021 in Hor
EU funding: FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem
27 Aug 2021
Agencia Estatal Boletín Oficial del Estado (anuncios únicos)
23 Aug 2021
Agencia Estatal Boletín Oficial del Estado (anuncios únicos)
3 Aug 2021
Company statute
3 Aug 2021
Other items: Admission to trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges of 1,661,175 ...
14 Jul 2021
No longer Officer: Tavares DA Silva Sandra Sofia
7 Jul 2021
Auditor: Kpmg Auditores SL
11 Jun 2021
Chair of the board (1) · Vice chair of the board (2)
11 Jun 2021
Chair of the board: E. de Leyva Perez, J. Orlow Seth · Member of the board: E. de Leyva Perez, Antonio Gallardo, Dorrepaal Karin · No longer Chair of the board: Dorrepaal Karin · Secretary (3)
11 Jun 2021
CEO (1)
11 Jun 2021
Company statute
11 Jun 2021
Capital: €21.6M
10 Jun 2021
CEO (1) · Member of the board (1)
10 Jun 2021
Member of the board (12)
21 May 2021
Officer (2)
21 May 2021
Officer (2)
21 May 2021
No longer Officer (1)
29 Mar 2021
Other concepts: Amendment of Article 13(2) of the Rules of Procedure of the Board of Directors
10 Mar 2021
No longer CEO (1) · No longer Member of the board (1)
12 Feb 2021
No longer Officer (2)
13 Jan 2021
No longer Officer (1)
31 Dec 2020
Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
28 Dec 2020
Vice chair of the board: C. Gallardo Pique
22 Dec 2020
Agencia Estatal Boletín Oficial del Estado (anuncios únicos)
Year 2020 in Epobase
4 European patent filings: Topical Formulation …
15 Dec 2020
Other concepts: Modification of Articles 5,13,17,21,25,34,36,39 and 40 of the Regulations of the Board of Directors
14 Dec 2020
Agencia Estatal Boletín Oficial del Estado (anuncios únicos)
9 Dec 2020
Other concepts: Admissions To Trading On The Stock Exchanges Of Madrid, Barcelona, Bilbao And Valencia Of The ...
30 Oct 2020
No longer Officer (2)
30 Oct 2020
Officer (1)
15 Oct 2020
Capital: €21.4M
8 Oct 2020
Auditor: Pricewaterhousecoopers Auditores SL
26 Aug 2020
Member of the board: B. Kimball Alexandra, Eva Lotta Coulter, J. Orlow Seth
26 Aug 2020
Company statute
20 Aug 2020
No longer Officer (2)
5 Aug 2020
No longer Officer (1)
5 Aug 2020
Officer (1)
Year 2020 in Euipotm
5 trademark filings (1 wordmark, 4 word figurative marks): LUXRAYO …
11 Jun 2020
Other items: Amendment of Articles 13.3, 14.3, 14.BIS.3 and 15.5 of the Regulations of the Board of Directors
20 May 2020
Officer (2)
2 Mar 2020
Officer (1)
20 Feb 2020
Officer (1)
12 Feb 2020
Officer (2)
31 Dec 2019
Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
23 Oct 2019
No longer Officer (1)
23 Oct 2019
Officer (1)
Year 2019 in Euipotm
7 trademark filings (6 wordmarks, 1 word figurative mark): A & P, KLISYRI, RAYKLIRA, RYNUVIAK, SAFLUSO, SIMSAKLIR …
Year 2019 in Epobase
6 European patent filings: Treatment of Psoriasis …
25 Jul 2019
Other concepts: Admission to trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges of 701,153 ...
10 Jul 2019
Auditor: Pricewaterhousecoopers Auditores SL
19 Jun 2019
Other concepts: Modification of the Conditions of the Issuance of Bonds THAT Motivated the Registration 265, Going To …
18 Jun 2019
Company statute
18 Jun 2019
Other concepts: Modification of Article 13 of the Regulations of the Board of Directors. Audit Committee
13 Jun 2019
Member of the board (7) · Chair of the board (2) · Vice chair of the board (1) · Secretary (2) · No longer Vice chair of the board (1) · No longer Member of the board (1) · No longer Secretary (1)
13 Jun 2019
Capital: €20.9M
30 May 2019
No longer Officer (1)
30 May 2019
Officer (1)
1 Apr 2019 in Hor
EU funding: Biomarkers in Atopic Dermatitis and Psoriasis
21 Mar 2019
Officer (2)
21 Mar 2019
Officer (1)
21 Mar 2019
Member of the board: E. de Leyva Perez · No longer Member of the board (1)
25 Jan 2019
Other items: Proof of the Closing of the Issue for an Amount of 250,000,000 Euros for Having Been Subscribed and ...
8 Jan 2019
Member of the board: Antonio Gallardo · Secretary: Antonio Gallardo · No longer Member of the board (1) · No longer Secretary (1)
31 Dec 2018
Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
18 Dec 2018
Amount of the issue: 250,000,000.00 Euros. 14.12.18
Year 2018 in Epobase
4 European patent filings: Pyrrole Derivatives AS ACC Inhibitors …
22 Nov 2018
Officer (1)
Year 2018 in Euipotm
15 trademark filings (9 wordmarks, 5 word figurative marks, 1 other mark): LYFIANZ, LYFSITE, OPTISUN D, SCIENCE YOU CAN SEE, SETLYNE, SOLAMINE D, SOLBALANCE D, VITDESUN, ZUUVE …
23 Oct 2018
Officer (2)
29 Aug 2018
No longer Officer (2)
2 Aug 2018
Other items: Admission of 902,547 Shares of Company A Trading on the Barcelona Stock Exchanges ...
2 Aug 2018
Registered Design: Inhalators
9 Jul 2018
Auditor: Pricewaterhousecoopers Auditores SL
14 Jun 2018
Capital: €20.9M
13 Jun 2018
CEO (1) · Member of the board (1)
12 Jun 2018
Other concepts: Constitution of the Deposit of the Communication of Termination of Shareholders' Agreements
31 May 2018
Officer (1)
28 May 2018
Member of the board (4) · Chair of the board (1) · Vice chair of the board (1) · Secretary (1)
23 Apr 2018
Officer (1)
22 Feb 2018
Officer (2)
22 Feb 2018
No longer Officer (1)
25 Jan 2018
No longer Officer (2)
4 Jan 2018
Officer (1)
4 Jan 2018
No longer Officer (4)
31 Dec 2017
Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
26 Dec 2017
Officer (3)
Year 2017 in Epobase
6 European patent filings: Compositions Comprising Linsitinib …
19 Oct 2017
CEO (1) · Member of the board (1) · No longer CEO (1) · No longer Member of the board (1) · No longer Secretary (1)
Year 2017 in Euipotm
20 trademark filings (8 wordmarks, 1 figurative mark, 11 word figurative marks): ACCLAIM / COPD, ALMIRALL SOFOTEC, CRESIA, LABORATORIOS ALMIRALL, MASADOL, ONALEX, SEAMON, TRIMSUL …
5 Sept 2017
Officer (1)
21 Aug 2017
No longer Officer (1)
20 Jul 2017
Auditor: Pricewaterhousecoopers Auditores SL
14 Jul 2017
Officer (1)
11 Jul 2017
Company statute
3 Jul 2017
Member of the board (1)
19 Jun 2017
Other items: Early Redemption of All Outstanding Debentures for A Nominal Amount of ...
25 Apr 2017
No longer Officer (1)
18 Apr 2017
No longer Officer (3)
23 Mar 2017
Officer (1)
23 Feb 2017
Officer (2)
23 Feb 2017
Officer (1)
2 Feb 2017
Officer (1)
12 Jan 2017
No longer Officer (7)
1 Jan 2017 in Fts
EU funding (€518,500): 720783 - Multi2Hycat - Multi-Site Organic-Inorganic Hybrid Catalysts for Multi-Step Chemical Processes
31 Dec 2016
Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
29 Nov 2016 in Hor
EU funding (€401,625): MULTI-site organic-inorganic HYbrid CATalysts for MULTI-step chemical processes
Year 2016 in Epobase
11 European patent filings: NEW Cyclohexylamine Derivatives Having Beta2 Adrenergic Agonist and M3 Muscarinic Antagonist Activities …
27 Oct 2016
No longer Officer (3)
21 Sept 2016
Chair of the board: J. Orlow Seth · Secretary (1)
21 Sept 2016
Chair of the board (2) · Member of the board (3) · Secretary (2)
7 Sept 2016
Member of the board (1)
7 Sept 2016
Member of the board: J. Orlow Seth
18 Aug 2016
No longer Officer (2)
8 Jul 2016
Officer (1)
8 Jul 2016
Officer (1)
8 Jul 2016
Officer (1)
8 Jul 2016
No longer Officer (2)
7 Jun 2016
Officer (1) · Officer: Tavares DA Silva Sandra Sofia
7 Jun 2016
Officer (1)
25 May 2016
Member of the board: C. Gallardo Pique, Antonio Gallardo
5 Apr 2016
Other items: Amendment of Article 16 of the Rules of Procedure of the Board of Directors
19 Feb 2016
Officer (1)
19 Feb 2016
No longer Officer (1)
19 Feb 2016
Officer (1)
19 Jan 2016
Other items: Amendment of Articles 5, 13, 14, 16, 17 and 21 of the Regulations of the Board of Directors
7 Jan 2016
Other concepts: Amortization and Payment of Obligations in the amount of 1,450,000 Euros
31 Dec 2015
Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
Year 2015 in Euipotm
4 trademark filings (2 wordmarks, 2 word figurative marks): BALNEUM OCTEN, ETUZRA …
Year 2015 in Epobase
9 European patent filings: Inhalation Composition Containing Aclidinium for Treatment of Asthma …
1 Sept 2015 in Fts
EU funding: 680565 - IBD - Intensified by Design® for the Intensification of Processes Involving Solids Handling
1 Sept 2015 in Fts
EU funding (€362,586): 680565 - IBD - Intensified by Design® for the Intensification of Processes Involving Solids Handling
11 Aug 2015 in Hor
EU funding: Intensified by Design® for the intensification of processes involving solids handling
24 Jul 2015
Officer (4)
24 Jul 2015
No longer Officer (1)
2 Jun 2015
Other concepts: Modification of Articles 3,6,8,12,13,14,15,16,20,25,26,27,28,29,30,32,33,34,35 and 40 of the …
2 Jun 2015
Company statute
25 Feb 2015
No longer Officer (2)
25 Feb 2015
Officer (2)
31 Dec 2014
Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
29 Dec 2014
Officer (3)
29 Dec 2014
No longer Officer (5)
Year 2014 in Epobase
14 European patent filings: Topical Pharmaceutical or Cosmetic Compositions Comprising Octenidine Dihydrochloride …
Year 2014 in Euipotm
16 trademark filings (11 wordmarks, 1 figurative mark, 4 word figurative marks): ALSONE, ASKDERMIS, BALMOCTEN, BALNIDEUM, BALOCT, BALOCTE, BALOCTEN, BALOCTET, ETULIRZ, ONYXIRAM, SIMPLE OUTSIDE …
26 Nov 2014
Officer (1)
26 Nov 2014
Officer (1)
26 Nov 2014
No longer Officer (4)
17 Oct 2014
No longer Officer (2)
2 Sept 2014
No longer Officer (1)
27 Aug 2014
Vice chair of the board: A. Gallardo Ballart · Member of the board: C. Gallardo Pique, Antonio Gallardo · No longer Member of the board (3)
31 Jul 2014
Officer (1)
2 Jul 2014
Auditor: Pricewaterhousecoopers Auditores SL
9 May 2014
Other items: Proof of Subscription and Disbursement of the Issued Debentures, for a Total Nominal Value of ...
31 Mar 2014
Amount of the issue: 325,000,000.00 Euros. 27.03.14
11 Mar 2014
Officer (1)
13 Feb 2014
Officer (3)
13 Feb 2014
No longer Officer (1)
31 Dec 2013
Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
16 Dec 2013
Secretary (1)
Year 2013 in Epobase
14 European patent filings: Aclidinium for USE in Increasing Physical Activity in Daily Life in a Patient Suffering From Chronic Obstructive Pulmonary Disease …
Year 2013 in Euipotm
13 trademark filings (7 wordmarks, 1 figurative mark, 5 word figurative marks): Almirall FOTOfarma, Almirall PHOTOpharma, COLAZID, ROSATIN, ROSATRIN, VOVELDI, ZELYRA …
7 Nov 2013
Officer (1)
7 Nov 2013
Officer (1)
26 Aug 2013
Officer (1)
31 Jul 2013
Other concepts: Admission to trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges of shares of ...
14 Jun 2013
Capital: €20.8M
13 Jun 2013
Member of the board: Dorrepaal Karin
16 Apr 2013
No longer Officer (1)
16 Apr 2013
Officer (2)
21 Mar 2013
Member of the board: Karin L. Dorrepaal · No longer Member of the board (1)
16 Jan 2013
Member of the board (1)
31 Dec 2012
Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
Year 2012 in Euipotm
45 wordmarks: ASSESS, BREANTIS, DAGNOTTA, DUAKLIR, DURZEKLI, DUVEKLIR, EKEPNI, EKEPNY, EKLEFEV, EKSYNIR, ELTUDO, ETUKLA, ETUKLI, EZENCLIR, EZENKLIR …
Year 2012 in Epobase
29 European patent filings: Topical Pharmaceutical Compositions Comprising Bexarotene and a Corticosteroids …
22 Nov 2012
No longer Officer (1)
22 Nov 2012
Officer (1)
1 Aug 2012
Other items: Admission to trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges of The 4,424,217 ...
13 Jun 2012
Member of the board (9) · Chair of the board (1) · CEO (1) · Vice chair of the board (2)
13 Jun 2012
Website
13 Jun 2012
Other items: Amendment of Articles 1,5,13,15,17,25,28 and 34 of the Regulations of the Board of Directors
13 Jun 2012
Company statute
13 Jun 2012
Capital: €20.5M
11 Jun 2012
Officer (5)
23 Apr 2012
Officer (1)
23 Apr 2012
No longer Officer (1)
16 Feb 2012
Officer (1)
16 Feb 2012
No longer Officer (6)
31 Dec 2011
Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
Year 2011 in Epobase
32 European patent filings: Azabiphenylaminobenzoic Acid Derivatives AS Dhodh Inhibitors …
14 Nov 2011
Officer (1)
Year 2011 in Euipotm
13 wordmarks: ACLIFORM-COPD, ARELBY, BELCOSTA, CRIADOR, DERBOLUM, DUNAVIO, FRONDAVA, FRONZEMA, GLENDAVA, IGOZEMA, IVELATIC, NEPTIMO, SUVETISTO
26 Oct 2011
Member of the board (1) · No longer Member of the board (1)
21 Oct 2011
Officer (1)
1 Sept 2011
No longer Officer (37)
26 Jul 2011
No longer Officer (1)
26 Jul 2011
Officer (35)
14 Jul 2011
Officer (1)
1 Jul 2011
CEO (1) · No longer CEO (1)
24 Jun 2011
Auditor: Pricewaterhousecoopers Auditores SL
8 Apr 2011
No longer Officer (2)
8 Apr 2011
Officer (1)
3 Feb 2011
Officer (2)
3 Feb 2011
No longer Officer (1)
31 Dec 2010
Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
Year 2010 in Epobase
35 European patent filings: Combinations Comprising Antimuscarininc Agents and Beta-Adrenergic Agonists …
8 Nov 2010
Officer (1)
8 Nov 2010
No longer Officer (1)
22 Oct 2010
Figurative mark
22 Oct 2010
Word figurative mark: “EkliraGenuair“
5 Aug 2010
No longer Officer (40)
5 Aug 2010
No longer Officer (3)
5 Aug 2010
No longer Officer (4)
5 Aug 2010
No longer Officer (1)
30 Jul 2010
Auditor: Deloitte SL
24 Mar 2010
Officer (1)
11 Feb 2010
Company statute
8 Feb 2010
Wordmark: “ALM“
5 Jan 2010
Officer (3)
5 Jan 2010
Officer (39)
31 Dec 2009
Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
30 Dec 2009 via Laboratorios Tecnobio SA
No longer Director: Laboratorios Tecnobio SA
Year 2009 in Epobase
31 European patent filings: Imidazopyridine Derivatives as JAK Inhibitors …
23 Nov 2009 in France
Name: ALMIRALL SA
Year 2009 in Euipotm
8 wordmarks: ACORVIO, ACTIKERALL, MONOVO, MUNDOSON, RETICEA, SOLANUS, XACTISIS, ZARSON
29 Jul 2009
No longer Officer (1)
20 Jul 2009
Auditor: Deloitte SL
22 Jun 2009
Name: Almirall SA · Company statute
30 Apr 2009 as Laboratorios Almirall SA
No longer Officer (1)
24 Mar 2009 as Laboratorios Almirall SA
Calls for Meetings
31 Dec 2008
Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
Year 2008 in Epobase
21 European patent filings: Combinations Comprising Antimuscarinic Agents and Beta-Adrenergic Agonists …
Year 2008 in Euipotm
18 trademark filings (10 wordmarks, 1 figurative mark, 7 word figurative marks): AIRFEV, BIOFENAC, DACTIBAL, FEVIDUAL, LET THEM STICK THEIR TONGUE OUT AT ALLERGY, MUPIDERM, OMEGA, POSIVAN, SOLUTIONS …
7 Apr 2008 as Laboratorios Almirall SA
Ordinary General Shareholders' Meeting
1 Jan 2008 as Laboratorios Almirall SA in France
Segment clas­si­fi­ca­tion
31 Dec 2007
Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
Year 2007 in Epobase
8 European patent filings: Substituted Pyrimidines AS Adenosine Receptor Antagonists …
14 Nov 2007 as Laboratorios Almirall SA
Extraordinary General Meeting of Shareholders
8 Nov 2007 via Almirall GmbH, also 20/10/2007
Shareholding: Hermal Pharma GmbH
Year 2007 in Euipotm
4 wordmarks: ACLIDINIUM, AFEVEN, AMIRAX, ONSETOL
9 Feb 2007 as Laboratorios Almirall SA in France
Name: LABORATORIOS ALMIRALL SA
1 Jan 2007 as Almirall Prodesfarma in France
Reg­is­tra­tion: 01/01/2007 · Address · Legal form: Société étrangère non immatriculée au RCS · Name: ALMIRALL PRODESFARMA
31 Dec 2006
Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
14 Dec 2006
Wordmark: “EBASTEL FLASH“
14 Dec 2006
Wordmark: “KESTINE FLASH“
23 Nov 2006
Patent: Derivatives of 4-(2-amino-1-hydroxyethyl)phenol ALS agonists of the beta-2-adrenergic receptor
Year 2006 in Epobase
8 European patent filings: Imidazopyridine Derivatives as a2B Adenosine Receptor Antagonists …
31 Dec 2005
Balance sheet for 31/12/2005 · Earnings statement for 31/12/2005
Year 2005 in Epobase
13 European patent filings: NEW Pyridothienopyrimidine Derivatives …
30 Aug 2005
Wordmark: “KESTINE“
13 Apr 2005 as Laboratorios Almirall SA
Wordmark: “ESTICIA“

Mentions

20 Jun 2024 via Almirall Ltd.
Shareholding, Voting rights, Beneficial Owner: Almirall Ltd

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Almirall SA, Barcelona, Spain" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close